1Elevan Bio is dedicated to advancing peptide therapeutics to improve human health and expand patient access to effective treatments. The company delivers FDA-approved and FDA-expanded-access pharmaceutical peptides aimed at treating chronic diseases in adjunctive, first-line, or potentially curative roles. By leveraging the body’s natural pathways, 1Elevan Bio is at the forefront of a shift away from costly, traditional small-molecule drugs with uncertain outcomes—ushering in a new beginning of pharmacological medicine rooted in science, empowerment, and innovation.

1Elevan Bio

Org chart

Teams

Offices